HDAC6-IN-29 (compound 11g), an iso-hydroxamic acid derivative, acts as an HDAC6 inhibitor. It shows significant antiproliferative activity against CAL-51 cells (IC50= 1.17 µM) and induces apoptosis, causing cell cycle arrest in the S phase, making it useful for tumor research.
Formula:
C38H51ClFN5O3
Target:
HDAC|||Apoptosis
* VAT and and shipping costs not included. Errors and price changes excepted
